Thomas H. Kramer - Concepedia

Author

Thomas H. Kramer

Also Known As

Krämer, Thomas, T H Kramer, T Kramer, T Krämer, T. H. KRAMER, T. H. Kramer, T. Kramer, T. Krämer, T.H. Kramer, T. H. Kramer

109

Publications

1.8K

Citations

H-Index

109

Concepts

All Affiliations

University of Arizona State University of New York Leipzig University Institute of Refrigeration Wilmington University

About

Thomas H. Kramer is an author at University of Arizona specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	21	618
2	Health Sciences	8	8	130
3	Public Health	5	5	180
4	Social Sciences	3	3	101
5	Natural Sciences	1	1	17

Thomas H. Kramer

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Refractory Status Epilepticus with Propofol: Clinical and Pharmacokinetic Findings Mark M. Stecker, Thomas H. Kramer, Eric C. Raps, Epilepsia	1998	236
Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. Thomas H. Kramer, Jennifer E. Shook, Wieslaw Kazmierski, Journal of Pharmacology and Experimental Therapeutics	1989	135
Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion Holger Stepan, Annegret Geipel, Friederike Schwarz, American Journal of Obstetrics and Gynecology GynecologyPregnancyObstetric HypertensionMaternal HealthCirculatory Soluble Endoglin	2008	119
Transdermal Fentanyl: Pharmacokinetics and Preliminary Clinical Evaluation Patricia M. Plezia, Thomas H. Kramer, Jennifer Linford, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	1989	113
Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration. Steven Weber, D L Greene, Shikha Sharma, Journal of Pharmacology and Experimental Therapeutics	1991	107
Maternal Plasma Concentrations of Soluble Endoglin in Pregnancies with Intrauterine Growth Restriction Holger Stepan, Thomas H. Kramer, R Faber The Journal of Clinical Endocrinology & Metabolism	2007	81
Topographical requirements for delta opioid ligands: Common structural features of dermenkephalin and deltorphin Aleksandra Misicka, Andrzej W. Lipkowski, Róbert Horváth, Life Sciences Molecular NeuroscienceFunctional SelectivityMedicineMechanism Of ActionNeuropeptide Receptor	1992	79
[Cyclic] [D-Pen2,D-Pen5]enkephalin analogs with increased affinity and selectivity for .delta.-opioid receptors Géza Tóth, Thomas H. Kramer, Richard J. Knapp, Journal of Medicinal Chemistry PharmacotherapyExperimental PharmacologyMolecular PharmacologyIncreased AffinityGreater Potency	1990	75
Medium Effects in Antibody-Catalyzed Reactions Cristina Lewis, Thomas H. Kramer, Suzanne Robinson, Science	1991	72
In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. Thomas H. Kramer, Peg Davis, Victor J. Hruby, Journal of Pharmacology and Experimental Therapeutics	1993	50

Page 1